Now, FISH on a Chip for Quicker, Cost-effective Cancer Diagnosis

June 20, 2007 at 4:32 PM Cancer News
  •   Print
  •   Share
  •   Comments
  •  Text 
Now, FISH on a Chip for Quicker, Cost-effective Cancer Diagnosis
Canadian researchers have for the first time miniaturised an important diagnostic test for cancer, and automated it onto a microfluidic chip.

The new technology, developed by University of Alberta researchers in Edmonton, opens up the possibility of better, faster cancer treatment and greater accessibility to fluorescent in situ hybridization (FISH), a complex test that detects mutations in chromosomes for a number of different types of cancer.

It is based on a microfluidic chip the size of a microscope slide, developed by Chris Backhouse, professor of electrical engineering, and cancer scientist Dr. Linda Pilarski, that can perform FISH on a handheld diagnostic device.

The researchers claim that the new system will allow FISH to be performed within a day for a fraction of the cost of current analysis methods, which take days conduct the test.

The rapid detection of chromosomal mutations with the help of new technology, say researchers, will significantly increase a doctor’s ability to tailor treatment strategies to target individual cancers.

“The ability to design ‘personalized’ therapies means that patients will be able to receive more effective treatments sooner and avoid exposure to side effects from treatments that will not help them,” Pilarski said.

“This is representative of how miniaturization can make our health care more accessible while creating new economic opportunities here in Alberta,” Backhouse added. The new technology has been hailed by the scientist fraternity.

"The work of Dr. Pilarski and her associates will have great impact, and quite quickly - on the diagnosis of patients with a broad spectrum of diseases," said Dr. Roderick McInnes, Scientific Director of the Canadian Institutes of Health Research Institute of Genetics.

The work is being published this month in IET Nanobiotechnology, and it will be presented at the 11th International Myeloma Workshop, a medical conference being held in Greece from June 25 to 30.

Source-ANI
LIN/S

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
Quiz on Cancer
Looking for information on cancer? Go through medindia's Cancer quiz.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Cancer
Complete Medindia Resources
News Categories:  
Child Health Center

Cancer Related News

» Cardio-Pulmonary Function can be a Strong Indicator for Survival Chances of Breast Cancer Patients » Post Surgery Will the Tumour Return? New Breast Cancer Test to Predict Exactly
» Scientists Develop Compound That Triggers Cancer Cell Death » Iraqi National Hopes to Find Affordable Treatment for His Cancer in India
» New Technique can Help Doctors Detect Pancreatic Cancer » Colorectal Cancer Risk Factors Probed
» Breast MRI 'Better Than Clinical Approach for Predicting Chemotherapy's Efficiency' » No Need for PSA-Based Screening for Prostate Cancer: Task Force
Read More >>